Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 6, 2020
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
[ Mon, Jan 06th 2020
] - WOPRAI
Fri, January 3, 2020
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
[ Fri, Jan 03rd 2020
] - WOPRAI
Thu, January 2, 2020
[ Thu, Jan 02nd 2020
] - WOPRAI
Randall Stanicky Maintained (AMRX) at Hold with Increased Target to $4 on, Jan 2nd, 2020
Randall Stanicky of RBC Capital, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Increased Target from $3 to $4 on, Jan 2nd, 2020.
Randall has made no other calls on AMRX in the last 4 months.
There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with Randall's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $4 on, Monday, November 11th, 2019
